List of Tables
Table 1. Global Posterior Pituitary for Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Posterior Pituitary for Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Posterior Pituitary for Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Posterior Pituitary for Injection Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Posterior Pituitary for Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Posterior Pituitary for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Posterior Pituitary for Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Posterior Pituitary for Injection Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Posterior Pituitary for Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Posterior Pituitary for Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Posterior Pituitary for Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Posterior Pituitary for Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Posterior Pituitary for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Posterior Pituitary for Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Posterior Pituitary for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Posterior Pituitary for Injection Sales by Region (K Dose), 2021–2026
Table 18. Global Posterior Pituitary for Injection Sales Market Share by Region (2021–2026)
Table 19. Global Posterior Pituitary for Injection Sales by Region (K Dose), 2027–2032
Table 20. Global Posterior Pituitary for Injection Sales Market Share by Region (2027–2032)
Table 21. Global Posterior Pituitary for Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Posterior Pituitary for Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Posterior Pituitary for Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Posterior Pituitary for Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Posterior Pituitary for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Posterior Pituitary for Injection Sales by Country (K Dose), 2021–2026
Table 27. North America Posterior Pituitary for Injection Sales by Country (K Dose), 2027–2032
Table 28. North America Posterior Pituitary for Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Posterior Pituitary for Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Posterior Pituitary for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Posterior Pituitary for Injection Sales by Country (K Dose), 2021–2026
Table 32. Europe Posterior Pituitary for Injection Sales by Country (K Dose), 2027–2032
Table 33. Europe Posterior Pituitary for Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Posterior Pituitary for Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Posterior Pituitary for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Posterior Pituitary for Injection Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Posterior Pituitary for Injection Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Posterior Pituitary for Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Posterior Pituitary for Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Posterior Pituitary for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Posterior Pituitary for Injection Sales by Country (K Dose), 2021–2026
Table 42. Latin America Posterior Pituitary for Injection Sales by Country (K Dose), 2027–2032
Table 43. Latin America Posterior Pituitary for Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Posterior Pituitary for Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Posterior Pituitary for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Posterior Pituitary for Injection Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Posterior Pituitary for Injection Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Posterior Pituitary for Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Posterior Pituitary for Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Posterior Pituitary for Injection Sales (K Dose) by Type (2021–2026)
Table 51. Global Posterior Pituitary for Injection Sales (K Dose) by Type (2027–2032)
Table 52. Global Posterior Pituitary for Injection Sales Market Share by Type (2021–2026)
Table 53. Global Posterior Pituitary for Injection Sales Market Share by Type (2027–2032)
Table 54. Global Posterior Pituitary for Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Posterior Pituitary for Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Posterior Pituitary for Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Posterior Pituitary for Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Posterior Pituitary for Injection Price (US$/Dose) by Type (2021–2026)
Table 59. Global Posterior Pituitary for Injection Price (US$/Dose) by Type (2027–2032)
Table 60. Global Posterior Pituitary for Injection Sales (K Dose) by Application (2021–2026)
Table 61. Global Posterior Pituitary for Injection Sales (K Dose) by Application (2027–2032)
Table 62. Global Posterior Pituitary for Injection Sales Market Share by Application (2021–2026)
Table 63. Global Posterior Pituitary for Injection Sales Market Share by Application (2027–2032)
Table 64. Global Posterior Pituitary for Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Posterior Pituitary for Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Posterior Pituitary for Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Posterior Pituitary for Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Posterior Pituitary for Injection Price (US$/Dose) by Application (2021–2026)
Table 69. Global Posterior Pituitary for Injection Price (US$/Dose) by Application (2027–2032)
Table 70. Eisai (Liaoning) Pharmaceutical Company Information
Table 71. Eisai (Liaoning) Pharmaceutical Description and Business Overview
Table 72. Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Product
Table 74. Eisai (Liaoning) Pharmaceutical Recent Developments/Updates
Table 75. Shanghai No. 1 Biochemical & Pharmaceutical Company Information
Table 76. Shanghai No. 1 Biochemical & Pharmaceutical Description and Business Overview
Table 77. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Product
Table 79. Shanghai No. 1 Biochemical & Pharmaceutical Recent Developments/Updates
Table 80. Nanjing Xinbai Pharmaceutical Company Information
Table 81. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 82. Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Product
Table 84. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
Table 85. Anhui Hongye Pharmaceutical Company Information
Table 86. Anhui Hongye Pharmaceutical Description and Business Overview
Table 87. Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Product
Table 89. Anhui Hongye Pharmaceutical Recent Developments/Updates
Table 90. Kamp Pharmaceutical Company Information
Table 91. Kamp Pharmaceutical Description and Business Overview
Table 92. Kamp Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Kamp Pharmaceutical Posterior Pituitary for Injection Product
Table 94. Kamp Pharmaceutical Recent Developments/Updates
Table 95. Chengdu Hepatunn Pharmaceutical Company Information
Table 96. Chengdu Hepatunn Pharmaceutical Description and Business Overview
Table 97. Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Product
Table 99. Chengdu Hepatunn Pharmaceutical Recent Developments/Updates
Table 100. Beijing Science Sun Company Information
Table 101. Beijing Science Sun Description and Business Overview
Table 102. Beijing Science Sun Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Beijing Science Sun Posterior Pituitary for Injection Product
Table 104. Beijing Science Sun Recent Developments/Updates
Table 105. Shanghai Harvest Pharmaceutical Company Information
Table 106. Shanghai Harvest Pharmaceutical Description and Business Overview
Table 107. Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Product
Table 109. Shanghai Harvest Pharmaceutical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Posterior Pituitary for Injection Distributors List
Table 113. Posterior Pituitary for Injection Customers List
Table 114. Posterior Pituitary for Injection Market Trends
Table 115. Posterior Pituitary for Injection Market Drivers
Table 116. Posterior Pituitary for Injection Market Challenges
Table 117. Posterior Pituitary for Injection Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Posterior Pituitary for Injection
Figure 2. Global Posterior Pituitary for Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Posterior Pituitary for Injection Market Share by Type: 2025 & 2032
Figure 4. Intramuscular Injection Product Picture
Figure 5. Intravenous Drip Product Picture
Figure 6. Global Posterior Pituitary for Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Posterior Pituitary for Injection Market Share by Application: 2025 & 2032
Figure 8. Lung or Bronchi Bleeding
Figure 9. Gastrointestinal Bleeding
Figure 10. Obstetric Oxytocia
Figure 11. Others
Figure 12. Global Posterior Pituitary for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Posterior Pituitary for Injection Market Size (US$ Million), 2021–2032
Figure 14. Global Posterior Pituitary for Injection Sales (K Dose), 2021–2032
Figure 15. Global Posterior Pituitary for Injection Average Price (US$/Dose), 2021–2032
Figure 16. Posterior Pituitary for Injection Report Years Considered
Figure 17. Posterior Pituitary for Injection Sales Share by Manufacturers in 2025
Figure 18. Global Posterior Pituitary for Injection Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Posterior Pituitary for Injection Players: Market Share by Revenue in Posterior Pituitary for Injection in 2025
Figure 20. Posterior Pituitary for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Posterior Pituitary for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Posterior Pituitary for Injection Sales Market Share by Country (2021–2032)
Figure 23. North America Posterior Pituitary for Injection Revenue Market Share by Country (2021–2032)
Figure 24. United States Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Posterior Pituitary for Injection Sales Market Share by Country (2021–2032)
Figure 27. Europe Posterior Pituitary for Injection Revenue Market Share by Country (2021–2032)
Figure 28. Germany Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Posterior Pituitary for Injection Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Posterior Pituitary for Injection Revenue Market Share by Region (2021–2032)
Figure 35. China Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Posterior Pituitary for Injection Sales Market Share by Country (2021–2032)
Figure 43. Latin America Posterior Pituitary for Injection Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Posterior Pituitary for Injection Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Posterior Pituitary for Injection Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Posterior Pituitary for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Posterior Pituitary for Injection by Type (2021–2032)
Figure 54. Global Revenue Market Share of Posterior Pituitary for Injection by Type (2021–2032)
Figure 55. Global Posterior Pituitary for Injection Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Posterior Pituitary for Injection by Application (2021–2032)
Figure 57. Global Revenue Market Share of Posterior Pituitary for Injection by Application (2021–2032)
Figure 58. Global Posterior Pituitary for Injection Price (US$/Dose) by Application (2021–2032)
Figure 59. Posterior Pituitary for Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
